PHILADELPHIA —A young woman sits in a restaurant waiting for her friends, excited about a night out on the town.

“Where RU and Lucy?!” she writes in a text message.

“Lucy’s not coming,” her friend replies.

“What a wimp!” the woman texts back.

“She just found out she has cervical cancer,” her friend writes in return, as the smile melts off the woman’s face, replaced by a look of shock and worry.

The video is one of many that GlaxoSmithKline has created as part of an information campaign to raise awareness about cervical cancer, along with the Web site HelpPreventCervicalCancer.com. GSK markets the human papillomavirus and cervical cancer vaccine Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant). The British drug maker is one of two companies that make HPV vaccines, the other being Merck’s Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant).

According to the GSK campaign, a woman in the United States is diagnosed with cervical cancer every 47 minutes, and it is the second most common cause of cancer-related death in women in their 20s and 30s.